Friday, September 25thFriday, 25 September 2026 - ET (Eastern Time, GMT-05:00)

This keynote session offers a transformative perspective, shifting the focus from numbers and financial frameworks to the realities of the patient experience. Through the lens of a patient, attendees will gain valuable insights into the patient journey and explore how a patient’s lived experience intersects with and is impacted by the financial decisions and strategic investments in the life sciences sector.

CPE Credits Available: 0.6

• Dissect the latest trends in capital markets and implications for biotech funding strategies
• Explore what investors prioritize across pre-commercial, clinical, and commercial stages, and learn how to align organizational goals with these expectations
• Discover strategies to leverage the recent upswing in capital markets to support growth, innovation and long-term success
• Examine non-traditional funding options, such as venture capital, private equity, and strategic partnerships and their role in driving financial sustainability

CPE Credits Available: 1.2

• Explore real-world strategies for balancing capital allocation across R&D, commercialization, and portfolio management
• Learn best practices for managing costs, optimizing resources and scaling operations in today’s funding environment
• Gain practical tools and frameworks to make smarter financial decisions and ensure successful commercialization outcomes

CPE Credits Available: 1.2

• Explore how today's biotech CFOs are reshaping their roles to become catalysts for innovation through driving transformation to elevate finance functions and enable sustainable growth and operational excellence
• Gain valuable perspectives from seasoned CFOs as they share their unique career paths, lessons learned, and actionable advice for emerging finance professionals
• Engage in discussions on overcoming industry challenges, fostering team resilience, and leveraging data-driven strategies to stay ahead in a dynamic business environment

CPE Credits Available: 1.2

• Delve into the complexities of clinical trial accruals and their critical role in bridging finance for commercial professionals and clinical teams
• Discover how biotech companies are leveraging innovative accounting tools and automated systems to transform budgeting, forecasting, and clinical trial management to reduce risks and improve operational efficiency
• Gain actionable strategies for designing processes that anticipate inaccuracies, ensuring accurate accrual recording while staying audit-ready

CPE Credits Available: 1.2

This dynamic session will feature three use case presentations from biotech professionals, each highlighting a unique, real-world example and outcome of AI application and adaptation strategies to improve efficiency and productivity in finance and operations.

• Explore how AI is transforming workflows in forecasting, GTN operations, clinical approval, and expense reporting
• Learn how AI adoption impacts financial reporting accuracy and strategies to address compliance concerns, including IP leakage, data security, and audit implications of AI adoption
• Discover how AI enables predictive finance models, driving proactive decision-making and operational agility

CPE Credits Available: 1.2

• Discover how to apply practical lessons from ERP implementations and transitions to advanced systems as organizations grow
• Explore ways to align ERP tools with company size, operational needs, and cross-departmental IT requirements
• Master the process of selecting and integrating essential software, including equity administration platforms and procurement-to-payment systems
• Uncover strategies to address implementation pain points and optimize post-implementation efficiency and financial reporting accuracy

CPE Credits Available: 1.0